OncoTherapy Science (4564) · RiskRestated
Conflict-of-interest risk from outside work by university and research-institution staff
First written in FY2017. 1 of 2 entries say "Restated". Latest entry: FY2018.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Risks of Conflicts of Interest and Reputational Damage Associated with Industry-Academia CollaborationA theme 4 companies write about · 4 as a headwind · 0 as a tailwind
3 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2018RestatedAnnual report
「Nevertheless, if conduct involving a conflict of interest or other such conduct occurs despite these precautions, it could harm the Group's interests, result in adverse consequences such as social condemnation, and consequently adversely affect the performance and other aspects of the Group.」
The company continues to disclose the risk of conflicts of interest arising from concurrent employment by faculty and staff of universities and research institutions. - FY2017First statedAnnual report
「Nevertheless, if conduct involving a conflict of interest or other such conduct occurs despite these precautions, it could harm the Group's interests, result in adverse consequences such as social condemnation, and consequently adversely affect the performance and other aspects of the Group.」
The company has disclosed the possibility of conflicts of interest arising when researchers at universities and research institutions concurrently serve as the company's directors, advisers or in similar positions as a new risk.